🔗 Share this article

Grammy-winning soul vocalist D’Angelo died on October 14 at 51 years old after a personal fight with pancreatic cancer.

“The brilliant light of our household has dimmed his light for us in the present world,” his relatives confirmed. “After a lengthy and courageous struggle with the disease, we are deeply saddened to announce that Michael D’Angelo Archer, recognized by his fans around the globe as D’Angelo, has been taken from us.”

D’Angelo left an indelible mark on music with his pioneering neo-soul sound and partnerships with high-profile artists.

He launched his first record, “Brown Sugar,” in 1995 to immediate acclaim. The album reached No. 4 on Billboard’s Top R&B Albums chart, went platinum soon after, and received multiple award nominations.

However, it was his second album, “Voodoo,” in 2000 that boosted his artistic journey into the limelight. The record debuted at No. 1 on both the R&B charts and the Billboard 200. He received two Grammy Awards: Best R&B Album and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” cemented D’Angelo’s standing as a icon, albeit a reluctant one, in the cultural zeitgeist. The personal depiction featured the singer, famously stripped down to his waist, performing directly into the lens.

D’Angelo stepped back from the public eye after putting out Voodoo and publicly struggled with drugs and alcohol. In 2005, he was involved in a serious car crash that put him in grave health.

More than a decade later, his third and final album, “Black Messiah” (2014), confirmed his lasting popularity with a further No. 1 debut on the R&B chart and a award for Best R&B Album.

Once more, in his own mysterious way, D’Angelo had limited public appearances in the following years.

The singer was scheduled as a headliner for the 2025 music event, but his appearance was called off, due to an “unforeseen medical delay.”

Even though details are sparse about D’Angelo’s health in the weeks before his death, he had apparently been hospitalized for an extended period and in palliative care for two weeks.

D’Angelo’s demise is a clear example of the harmful impact of pancreatic cancer, one of the most deadly and hardest to prevent forms of the disease, on a gifted artist whose existence was ended too soon.

“We are saddened that he can only leave dear memories with his loved ones, but we are eternally grateful for the legacy of extraordinarily moving songs he has left us,” his family expressed.

Pancreatic Cancer: Deadly and Difficult to Avoid

Pancreatic cancer affects the pancreas, a tiny gland that produces the hormone insulin and plays an essential role in digestion, among other functions. The position and dimensions of the organ in the body make it more challenging to detect malignancy.

Although pancreatic cancer makes up only about 3% of cancer diagnoses annually in the United States, it is responsible for 7% of malignancy fatalities.

Almost 70,000 individuals will be found to have pancreatic cancer and about fifty-two thousand will succumb to the disease in 2025.

“This malignancy is one of the most lethal diseases, with an aggressive tumor and dismal outcomes. We have limited and poor therapies, and a narrow opportunity to make a significant difference on the well-being of people,” said a cancer specialist.

Because this disease rarely causes early symptoms, it’s frequently diagnosed only once the condition is advanced. Although a individual has indicators they are often vague and may be mistaken for a number of everyday ailments.

“Currently, there is no effective method to identify this malignancy in the initial phases, except for paying attention to physical changes and speaking with your doctor if there are unfamiliar signs,” said a medical director.

Frequent indicators of this disease encompass:

• discomfort in the stomach or back
• weight loss
• jaundice
• loss of appetite
• dark urine
• pale or fatty bowel movements
• diarrhea
• excessive hunger or thirst
• feeling sick

At 51 years old, D’Angelo’s demise is an exception, as this malignancy is most common in adults in the 65 to 75 range. However, numerous malignancies, such as pancreatic cancer, have become increasingly prevalent among younger people.

“Pancreatic cancer diagnosed before the age of 50 is considered uncommon, yet concerningly, clinicians are beginning to see a rising count of younger individuals affected by this disease,” said a expert.

Genetic Background Impacts Cancer Risk

Without effective screening tools for this malignancy, professionals stressed the importance of knowing your relatives’ cancer history. Certain contributing elements, such as tobacco use and obesity also play a role in the onset of this disease.

Black individuals have the highest incidence of pancreatic cancer in the U.S. and are more prone to be found to have untreatable disease.

“The initial action toward lowering one’s chance of this condition is understanding personal risk factors. People should review their genetic background, hereditary factors, and medical conditions, such as blood sugar disease, long-term pancreas inflammation, or overweight that may increase their vulnerability,” advised a specialist.

Inherited genetic risk factors are linked to as much as 10% of all this malignancy instances. If a relative in your family has had pancreatic cancer, you may want to think about DNA analysis.

“For individuals with a family history of pancreatic cancer or those carrying elevated risk genetic mutations, screening may involve sophisticated scans such as MRI scans or endoscopic ultrasound (EUS) to detect initial alterations in the pancreas,” he clarified.

For those wishing to lower their chance, habit adjustments may have an effect. The most effective action you can take to lower your risk of pancreatic cancer is to quit smoking, and if you are a non-smoker, avoid exposure altogether.

Heavy drinking is associated with pancreatitis, a contributing element for this malignancy, so limiting or avoiding alcohol may help lower your chance.

Controlling your weight or losing weight may also aid reduce your risk. Individuals with excess weight are twenty percent more prone to develop pancreatic cancer. This malignancy also occurs more often in those with diabetes, and reducing weight can also lower the risk of adult-onset diabetes.

In spite of this disease’s poor prognosis, there is reason for optimism.

“We are making progress with treatments and newer combination chemotherapy. There are developing precision medicines that already are making an impact,” said a expert.

For many individuals, however, education about this uncommon but {dev